LalaChin personal page - To The Moon

LalaChin

No personal profile

5Follow

1Followers

0Topic

0Badge

2022-12-02

[Drowsy]

Payrolls Increased 263,000 in November, Much Better Than Expected

2022-05-21

Buy buy buy

Sorry, the original content has been removed

2022-01-19

All Zogenix shareholders are on drugs now🤪

Zogenix Shares Popped 56% in Premarket Trading

2022-01-06

BUY.

Nasdaq posts biggest daily drop since Feb after 'hawkish' Fed minutes

Go to Tiger App to see more news

{"i18n":{"language":"en_US"},"userPageInfo":{"id":4099390898791420,"uuid":"4099390898791420","gmtCreate":1636289361504,"gmtModify":1636289361504,"name":"LalaChin","pinyin":"lalachin","introduction":"","introductionEn":"","signature":"","avatar":"https://static.laohu8.com/default-avatar.jpg","hat":null,"hatId":null,"hatName":null,"vip":1,"status":2,"fanSize":1,"headSize":5,"tweetSize":5,"questionSize":0,"limitLevel":999,"accountStatus":4,"level":{"id":0,"name":"","nameTw":"","represent":"","factor":"","iconColor":"","bgColor":""},"themeCounts":0,"badgeCounts":0,"badges":[],"moderator":false,"superModerator":false,"manageSymbols":null,"badgeLevel":null,"boolIsFan":false,"boolIsHead":false,"favoriteSize":0,"symbols":null,"coverImage":null,"realNameVerified":"success","userBadges":[{"badgeId":"44212b71d0be4ec88898348dbe882e03-3","templateUuid":"44212b71d0be4ec88898348dbe882e03","name":"President Tiger","description":"The transaction amount of the securities account reaches $1,000,000","bigImgUrl":"https://static.tigerbbs.com/fbeac6bb240db7da8b972e5183d050ba","smallImgUrl":"https://static.tigerbbs.com/436cdf80292b99f0a992e78750ac4e3a","grayImgUrl":"https://static.tigerbbs.com/506a259a7b456f037592c3b23c779599","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.07.14","exceedPercentage":"93.97%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1101},{"badgeId":"1026c425416b44e0aac28c11a0848493-1","templateUuid":"1026c425416b44e0aac28c11a0848493","name":"Debut Tiger","description":"Join the tiger community for 500 days","bigImgUrl":"https://static.tigerbbs.com/0e4d0ca1da0456dc7894c946d44bf9ab","smallImgUrl":"https://static.tigerbbs.com/0f2f65e8ce4cfaae8db2bea9b127f58b","grayImgUrl":"https://static.tigerbbs.com/c5948a31b6edf154422335b265235809","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2023.03.23","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1001},{"badgeId":"972123088c9646f7b6091ae0662215be-2","templateUuid":"972123088c9646f7b6091ae0662215be","name":"Master Trader","description":"Total number of securities or futures transactions reached 100","bigImgUrl":"https://static.tigerbbs.com/ad22cfbe2d05aa393b18e9226e4b0307","smallImgUrl":"https://static.tigerbbs.com/36702e6ff3ffe46acafee66cc85273ca","grayImgUrl":"https://static.tigerbbs.com/d52eb88fa385cf5abe2616ed63781765","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2022.12.03","exceedPercentage":"80.50%","individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100},{"badgeId":"a83d7582f45846ffbccbce770ce65d84-1","templateUuid":"a83d7582f45846ffbccbce770ce65d84","name":"Real Trader","description":"Completed a transaction","bigImgUrl":"https://static.tigerbbs.com/2e08a1cc2087a1de93402c2c290fa65b","smallImgUrl":"https://static.tigerbbs.com/4504a6397ce1137932d56e5f4ce27166","grayImgUrl":"https://static.tigerbbs.com/4b22c79415b4cd6e3d8ebc4a0fa32604","redirectLinkEnabled":0,"redirectLink":null,"hasAllocated":1,"isWearing":0,"stamp":null,"stampPosition":0,"hasStamp":0,"allocationCount":1,"allocatedDate":"2021.12.29","exceedPercentage":null,"individualDisplayEnabled":0,"backgroundColor":null,"fontColor":null,"individualDisplaySort":0,"categoryType":1100}],"userBadgeCount":4,"currentWearingBadge":null,"individualDisplayBadges":null,"crmLevel":8,"crmLevelSwitch":1,"location":null,"starInvestorFollowerNum":0,"starInvestorFlag":false,"starInvestorOrderShareNum":0,"subscribeStarInvestorNum":0,"ror":null,"winRationPercentage":null,"showRor":false,"investmentPhilosophy":null,"starInvestorSubscribeFlag":false},"baikeInfo":{},"tab":"post","tweets":[{"id":9965520814,"gmtCreate":1669988083739,"gmtModify":1676538283469,"author":{"id":"4099390898791420","authorId":"4099390898791420","name":"LalaChin","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"[Drowsy]&nbsp;","listText":"[Drowsy]&nbsp;","text":"[Drowsy]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9965520814","repostId":"1188313465","repostType":4,"repost":{"id":"1188313465","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1669994807,"share":"https://www.laohu8.com/m/news/1188313465?lang=&edition=full","pubTime":"2022-12-02 23:26","market":"us","language":"en","title":"Payrolls Increased 263,000 in November, Much Better Than Expected ","url":"https://stock-news.laohu8.com/highlight/detail?id=1188313465","media":"Tiger Newspress","summary":"Job growth was much better than expected in November despite the Federal Reserve’s aggressive effort","content":"<html><head></head><body><p>Job growth was much better than expected in November despite the Federal Reserve’s aggressive efforts to slow the labor market and tackle inflation.</p><p>Nonfarm payrolls increased 263,000 for the month while the unemployment rate was 3.7%, the Labor Department reported Friday. Economists surveyed by Dow Jones had been looking for an increase of 200,000 on the payrolls number and 3.7% for the jobless rate.</p><p><img src=\"https://static.tigerbbs.com/2a60382bd5ea540fed594e95d940cf4a\" tg-width=\"1500\" tg-height=\"1408\" referrerpolicy=\"no-referrer\"/></p><p>The monthly gain was a slight decrease from October’s upwardly revised 284,000.</p><p>The numbers likely will do little to slow a Fed that has been raising interest rates steadily this year to bring down inflation still running near its highest level in more than 40 years.</p><p>In another blow to the Fed’s anti-inflation efforts, average hourly earnings jumped 0.6% for the month, double the Dow Jones estimate. Wages were up 5.1% on a year-over-year basis, also well above the 4.6% expectation.</p><p>Futures tied to the Dow Jones Industrial Average plunged following the report, falling more than 400 points as the hot jobs report could make the Fed even more aggressive.</p><p>Leisure and hospitality led the job gains, adding 88,000 positions.</p><p>Other sector gainers included health care (45,000), government (42,000) and other services, a category that includes personal and laundry services and which showed a total gain of 24,000. Social assistance saw a rise of 23,000, which the Labor Department said brings the sector back to where it was in February 2020 before the Covid pandemic.</p><p>Construction added 20,000 positions, while information was up 19,000 and manufacturing saw a gain of 14,000.</p><p>On the downside, retail establishments reported a loss of 30,000 positions heading into what is expected to be a busy holiday shopping season. Transportation and warehousing also saw a decline, down 15,000.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Payrolls Increased 263,000 in November, Much Better Than Expected </title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nPayrolls Increased 263,000 in November, Much Better Than Expected \n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-12-02 23:26</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Job growth was much better than expected in November despite the Federal Reserve’s aggressive efforts to slow the labor market and tackle inflation.</p><p>Nonfarm payrolls increased 263,000 for the month while the unemployment rate was 3.7%, the Labor Department reported Friday. Economists surveyed by Dow Jones had been looking for an increase of 200,000 on the payrolls number and 3.7% for the jobless rate.</p><p><img src=\"https://static.tigerbbs.com/2a60382bd5ea540fed594e95d940cf4a\" tg-width=\"1500\" tg-height=\"1408\" referrerpolicy=\"no-referrer\"/></p><p>The monthly gain was a slight decrease from October’s upwardly revised 284,000.</p><p>The numbers likely will do little to slow a Fed that has been raising interest rates steadily this year to bring down inflation still running near its highest level in more than 40 years.</p><p>In another blow to the Fed’s anti-inflation efforts, average hourly earnings jumped 0.6% for the month, double the Dow Jones estimate. Wages were up 5.1% on a year-over-year basis, also well above the 4.6% expectation.</p><p>Futures tied to the Dow Jones Industrial Average plunged following the report, falling more than 400 points as the hot jobs report could make the Fed even more aggressive.</p><p>Leisure and hospitality led the job gains, adding 88,000 positions.</p><p>Other sector gainers included health care (45,000), government (42,000) and other services, a category that includes personal and laundry services and which showed a total gain of 24,000. Social assistance saw a rise of 23,000, which the Labor Department said brings the sector back to where it was in February 2020 before the Covid pandemic.</p><p>Construction added 20,000 positions, while information was up 19,000 and manufacturing saw a gain of 14,000.</p><p>On the downside, retail establishments reported a loss of 30,000 positions heading into what is expected to be a busy holiday shopping season. Transportation and warehousing also saw a decline, down 15,000.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".DJI":"道琼斯",".IXIC":"NASDAQ Composite",".SPX":"S&P 500 Index"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1188313465","content_text":"Job growth was much better than expected in November despite the Federal Reserve’s aggressive efforts to slow the labor market and tackle inflation.Nonfarm payrolls increased 263,000 for the month while the unemployment rate was 3.7%, the Labor Department reported Friday. Economists surveyed by Dow Jones had been looking for an increase of 200,000 on the payrolls number and 3.7% for the jobless rate.The monthly gain was a slight decrease from October’s upwardly revised 284,000.The numbers likely will do little to slow a Fed that has been raising interest rates steadily this year to bring down inflation still running near its highest level in more than 40 years.In another blow to the Fed’s anti-inflation efforts, average hourly earnings jumped 0.6% for the month, double the Dow Jones estimate. Wages were up 5.1% on a year-over-year basis, also well above the 4.6% expectation.Futures tied to the Dow Jones Industrial Average plunged following the report, falling more than 400 points as the hot jobs report could make the Fed even more aggressive.Leisure and hospitality led the job gains, adding 88,000 positions.Other sector gainers included health care (45,000), government (42,000) and other services, a category that includes personal and laundry services and which showed a total gain of 24,000. Social assistance saw a rise of 23,000, which the Labor Department said brings the sector back to where it was in February 2020 before the Covid pandemic.Construction added 20,000 positions, while information was up 19,000 and manufacturing saw a gain of 14,000.On the downside, retail establishments reported a loss of 30,000 positions heading into what is expected to be a busy holiday shopping season. Transportation and warehousing also saw a decline, down 15,000.","news_type":1},"isVote":1,"tweetType":1,"viewCount":10,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9021477689,"gmtCreate":1653098739342,"gmtModify":1676535223816,"author":{"id":"4099390898791420","authorId":"4099390898791420","name":"LalaChin","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Buy buy buy&nbsp;","listText":"Buy buy buy&nbsp;","text":"Buy buy buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9021477689","repostId":"2236015712","repostType":2,"isVote":1,"tweetType":1,"viewCount":91,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9004660605,"gmtCreate":1642584671029,"gmtModify":1676533725062,"author":{"id":"4099390898791420","authorId":"4099390898791420","name":"LalaChin","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"All Zogenix shareholders are&nbsp;on drugs now🤪","listText":"All Zogenix shareholders are&nbsp;on drugs now🤪","text":"All Zogenix shareholders are on drugs now🤪","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004660605","repostId":"1154721698","repostType":4,"repost":{"id":"1154721698","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642583987,"share":"https://www.laohu8.com/m/news/1154721698?lang=&edition=full","pubTime":"2022-01-19 17:19","market":"us","language":"en","title":"Zogenix Shares Popped 56% in Premarket Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1154721698","media":"Tiger Newspress","summary":"Zogenix shares popped 56% in premarket trading as UCB agreed to buy Zogenix for up to $1.9 billion.B","content":"<html><head></head><body><p>Zogenix shares popped 56% in premarket trading as UCB agreed to buy Zogenix for up to $1.9 billion.</p><p><img src=\"https://static.tigerbbs.com/92b5f5e39f76c65983922a9028031295\" tg-width=\"840\" tg-height=\"622\" referrerpolicy=\"no-referrer\"/></p><p>Belgian pharmaceutical company UCB SA agreed to buy Zogenix Inc., a U.S. maker of drugs to treat seizures and rare diseases, for as much as $1.9 billion, expanding its portfolio to treat epilepsy.</p><p>Investors will get $26 in cash for every Zogenix share, plus a potential $2 per share payment if the U.S. company’s Fintepla drug gets regulatory approval for Lennox-Gastaut syndrome by the end of 2023, UCB said Wednesday. The initial payment is 66% higher than Tuesday’s closing price.</p><p>Lennox-Gastaut syndrome is an orphan disease that causes seizures. UCB has been expanding in therapies for rare ailments, like many big rivals including Sanofi, Takeda Pharmaceutical Co. and Roche Holding AG, as they can charge more for unique life-saving drugs than for routine treatments.</p><p>UCB shares fell as much as 0.9% in Brussels Wednesday morning.</p><p>Fintepla has already received regulatory approval in the U.S. and European Union for seizures caused by Dravet syndrome, a rare form of epilepsy.</p><p>UCB said it will finance the deal with cash and a loan. Lazard and Barclays are the company’s financial advisors, while Bank of America Securities and SVB Leerink advised Zogenix.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zogenix Shares Popped 56% in Premarket Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZogenix Shares Popped 56% in Premarket Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-19 17:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Zogenix shares popped 56% in premarket trading as UCB agreed to buy Zogenix for up to $1.9 billion.</p><p><img src=\"https://static.tigerbbs.com/92b5f5e39f76c65983922a9028031295\" tg-width=\"840\" tg-height=\"622\" referrerpolicy=\"no-referrer\"/></p><p>Belgian pharmaceutical company UCB SA agreed to buy Zogenix Inc., a U.S. maker of drugs to treat seizures and rare diseases, for as much as $1.9 billion, expanding its portfolio to treat epilepsy.</p><p>Investors will get $26 in cash for every Zogenix share, plus a potential $2 per share payment if the U.S. company’s Fintepla drug gets regulatory approval for Lennox-Gastaut syndrome by the end of 2023, UCB said Wednesday. The initial payment is 66% higher than Tuesday’s closing price.</p><p>Lennox-Gastaut syndrome is an orphan disease that causes seizures. UCB has been expanding in therapies for rare ailments, like many big rivals including Sanofi, Takeda Pharmaceutical Co. and Roche Holding AG, as they can charge more for unique life-saving drugs than for routine treatments.</p><p>UCB shares fell as much as 0.9% in Brussels Wednesday morning.</p><p>Fintepla has already received regulatory approval in the U.S. and European Union for seizures caused by Dravet syndrome, a rare form of epilepsy.</p><p>UCB said it will finance the deal with cash and a loan. Lazard and Barclays are the company’s financial advisors, while Bank of America Securities and SVB Leerink advised Zogenix.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZGNX":"Zogenix"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154721698","content_text":"Zogenix shares popped 56% in premarket trading as UCB agreed to buy Zogenix for up to $1.9 billion.Belgian pharmaceutical company UCB SA agreed to buy Zogenix Inc., a U.S. maker of drugs to treat seizures and rare diseases, for as much as $1.9 billion, expanding its portfolio to treat epilepsy.Investors will get $26 in cash for every Zogenix share, plus a potential $2 per share payment if the U.S. company’s Fintepla drug gets regulatory approval for Lennox-Gastaut syndrome by the end of 2023, UCB said Wednesday. The initial payment is 66% higher than Tuesday’s closing price.Lennox-Gastaut syndrome is an orphan disease that causes seizures. UCB has been expanding in therapies for rare ailments, like many big rivals including Sanofi, Takeda Pharmaceutical Co. and Roche Holding AG, as they can charge more for unique life-saving drugs than for routine treatments.UCB shares fell as much as 0.9% in Brussels Wednesday morning.Fintepla has already received regulatory approval in the U.S. and European Union for seizures caused by Dravet syndrome, a rare form of epilepsy.UCB said it will finance the deal with cash and a loan. Lazard and Barclays are the company’s financial advisors, while Bank of America Securities and SVB Leerink advised Zogenix.","news_type":1},"isVote":1,"tweetType":1,"viewCount":132,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9008871847,"gmtCreate":1641426609993,"gmtModify":1676533613310,"author":{"id":"4099390898791420","authorId":"4099390898791420","name":"LalaChin","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"BUY.","listText":"BUY.","text":"BUY.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9008871847","repostId":"2201255535","repostType":2,"repost":{"id":"2201255535","weMediaInfo":{"introduction":"Reuters.com brings you the latest news from around the world, covering breaking news in markets, business, politics, entertainment and technology","home_visible":1,"media_name":"Reuters","id":"1036604489","head_image":"https://static.tigerbbs.com/443ce19704621c837795676028cec868"},"pubTimestamp":1641423313,"share":"https://www.laohu8.com/m/news/2201255535?lang=&edition=full","pubTime":"2022-01-06 06:55","market":"us","language":"en","title":"Nasdaq posts biggest daily drop since Feb after 'hawkish' Fed minutes","url":"https://stock-news.laohu8.com/highlight/detail?id=2201255535","media":"Reuters","summary":"* S&P 500 posts biggest daily pct fall since Nov. 26* Fed minutes show officials said labor market \"very tight\"* Indexes: Dow down 1.1%, S&P 500 down 1.9%, Nasdaq down 3.3%NEW YORK, Jan 5 (Reuters) - ","content":"<html><head></head><body><p>* S&amp;P 500 posts biggest daily pct fall since Nov. 26</p><p>* Fed minutes show officials said labor market &#34;very tight&#34;</p><p>* Indexes: Dow down 1.1%, S&amp;P 500 down 1.9%, Nasdaq down 3.3%</p><p>NEW YORK, Jan 5 (Reuters) - U.S. stocks fell sharply on Wednesday, with the Nasdaq plunging more than 3% in its biggest one-day percentage drop since February, after U.S. Federal Reserve meeting minutes signaled the central bank may raise interest rates sooner than expected.</p><p>The S&amp;P 500 fell more than 1%, its biggest daily percentage decline since Nov. 26, the first day of trading after news of the Omicron variant of the coronavirus.</p><p>The S&amp;P 500 and Nasdaq quickly extended their declines after the release of the minutes, which investors viewed as more hawkish than they had feared. The Dow, which hit a record high earlier in the day, reversed course and ended down more than 1%.</p><p>The selloff was broad, with all S&amp;P sectors ending in the red, and Wall Street&#39;s fear gauge, the Cboe Volatility index, closing at its highest level since Dec. 21.</p><p>In the minutes from the Fed&#39;s Dec. 14-15 policy meeting, central bank policymakers said a &#34;very tight&#34; job market and unabated inflation might require the Fed to raise rates sooner and begin reducing its overall asset holdings as a second brake on the economy.</p><p>&#34;Indications that the Fed is very concerned about inflation could quickly create a view that the Fed will aggressively tighten in 2022,&#34; said David Carter, chief investment officer at Lenox Wealth Advisors in New York, calling the minutes &#34;more hawkish than expected.&#34;</p><p>The S&amp;P 500 technology sector fell 3.1% and was the biggest drag on the benchmark index, while the rate-sensitive real estate sector dropped 3.2% in its biggest daily percentage decline since Jan. 4, 2021.</p><p>The Dow Jones Industrial Average fell 392.54 points, or 1.07%, to 36,407.11, the S&amp;P 500 lost 92.96 points, or 1.94%, to 4,700.58 and the Nasdaq Composite dropped 522.54 points, or 3.34%, to 15,100.17.</p><p>Rising interest rates increase borrowing costs for businesses and consumers, and higher rates can depress stock multiples, especially for technology and other growth stocks.</p><p>Growth shares have been under pressure from a recent rise in U.S. Treasury yields.</p><p>The Russell 2000 index also suffered its biggest one-day drop since Nov. 26, while the S&amp;P 500 financials index fell 1.3%, a day after it registered an all-time closing high.</p><p>Policymakers in December agreed to hasten the end of their pandemic-era program of bond purchases, and issued forecasts anticipating three quarter-percentage-point rate increases during 2022. The Fed&#39;s benchmark overnight interest rate is currently set near zero.</p><p>Early in the day, an ADP National Employment report showed private payrolls increased by 807,000 jobs last month, more than double of what economists polled by Reuters had forecast.</p><p>The report comes ahead of the Labor Department&#39;s more comprehensive and closely watched nonfarm payrolls data for December on Friday.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 4.32-to-1 ratio; on Nasdaq, a 4.22-to-1 ratio favored decliners.</p><p>The S&amp;P 500 posted 59 new 52-week highs and 1 new lows; the Nasdaq Composite recorded 81 new highs and 307 new lows.</p><p>Volume on U.S. exchanges was 12.18 billion shares, compared with the 10.4 billion average for the full session over the last 20 trading days.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Nasdaq posts biggest daily drop since Feb after 'hawkish' Fed minutes</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nNasdaq posts biggest daily drop since Feb after 'hawkish' Fed minutes\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1036604489\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/443ce19704621c837795676028cec868);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Reuters </p>\n<p class=\"h-time\">2022-01-06 06:55</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>* S&amp;P 500 posts biggest daily pct fall since Nov. 26</p><p>* Fed minutes show officials said labor market &#34;very tight&#34;</p><p>* Indexes: Dow down 1.1%, S&amp;P 500 down 1.9%, Nasdaq down 3.3%</p><p>NEW YORK, Jan 5 (Reuters) - U.S. stocks fell sharply on Wednesday, with the Nasdaq plunging more than 3% in its biggest one-day percentage drop since February, after U.S. Federal Reserve meeting minutes signaled the central bank may raise interest rates sooner than expected.</p><p>The S&amp;P 500 fell more than 1%, its biggest daily percentage decline since Nov. 26, the first day of trading after news of the Omicron variant of the coronavirus.</p><p>The S&amp;P 500 and Nasdaq quickly extended their declines after the release of the minutes, which investors viewed as more hawkish than they had feared. The Dow, which hit a record high earlier in the day, reversed course and ended down more than 1%.</p><p>The selloff was broad, with all S&amp;P sectors ending in the red, and Wall Street&#39;s fear gauge, the Cboe Volatility index, closing at its highest level since Dec. 21.</p><p>In the minutes from the Fed&#39;s Dec. 14-15 policy meeting, central bank policymakers said a &#34;very tight&#34; job market and unabated inflation might require the Fed to raise rates sooner and begin reducing its overall asset holdings as a second brake on the economy.</p><p>&#34;Indications that the Fed is very concerned about inflation could quickly create a view that the Fed will aggressively tighten in 2022,&#34; said David Carter, chief investment officer at Lenox Wealth Advisors in New York, calling the minutes &#34;more hawkish than expected.&#34;</p><p>The S&amp;P 500 technology sector fell 3.1% and was the biggest drag on the benchmark index, while the rate-sensitive real estate sector dropped 3.2% in its biggest daily percentage decline since Jan. 4, 2021.</p><p>The Dow Jones Industrial Average fell 392.54 points, or 1.07%, to 36,407.11, the S&amp;P 500 lost 92.96 points, or 1.94%, to 4,700.58 and the Nasdaq Composite dropped 522.54 points, or 3.34%, to 15,100.17.</p><p>Rising interest rates increase borrowing costs for businesses and consumers, and higher rates can depress stock multiples, especially for technology and other growth stocks.</p><p>Growth shares have been under pressure from a recent rise in U.S. Treasury yields.</p><p>The Russell 2000 index also suffered its biggest one-day drop since Nov. 26, while the S&amp;P 500 financials index fell 1.3%, a day after it registered an all-time closing high.</p><p>Policymakers in December agreed to hasten the end of their pandemic-era program of bond purchases, and issued forecasts anticipating three quarter-percentage-point rate increases during 2022. The Fed&#39;s benchmark overnight interest rate is currently set near zero.</p><p>Early in the day, an ADP National Employment report showed private payrolls increased by 807,000 jobs last month, more than double of what economists polled by Reuters had forecast.</p><p>The report comes ahead of the Labor Department&#39;s more comprehensive and closely watched nonfarm payrolls data for December on Friday.</p><p>Declining issues outnumbered advancing ones on the NYSE by a 4.32-to-1 ratio; on Nasdaq, a 4.22-to-1 ratio favored decliners.</p><p>The S&amp;P 500 posted 59 new 52-week highs and 1 new lows; the Nasdaq Composite recorded 81 new highs and 307 new lows.</p><p>Volume on U.S. exchanges was 12.18 billion shares, compared with the 10.4 billion average for the full session over the last 20 trading days.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{".SPX":"S&P 500 Index",".IXIC":"NASDAQ Composite","BK4559":"巴菲特持仓","BK4534":"瑞士信贷持仓","BK4504":"桥水持仓","BK4550":"红杉资本持仓",".DJI":"道琼斯","SPY":"标普500ETF"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2201255535","content_text":"* S&P 500 posts biggest daily pct fall since Nov. 26* Fed minutes show officials said labor market \"very tight\"* Indexes: Dow down 1.1%, S&P 500 down 1.9%, Nasdaq down 3.3%NEW YORK, Jan 5 (Reuters) - U.S. stocks fell sharply on Wednesday, with the Nasdaq plunging more than 3% in its biggest one-day percentage drop since February, after U.S. Federal Reserve meeting minutes signaled the central bank may raise interest rates sooner than expected.The S&P 500 fell more than 1%, its biggest daily percentage decline since Nov. 26, the first day of trading after news of the Omicron variant of the coronavirus.The S&P 500 and Nasdaq quickly extended their declines after the release of the minutes, which investors viewed as more hawkish than they had feared. The Dow, which hit a record high earlier in the day, reversed course and ended down more than 1%.The selloff was broad, with all S&P sectors ending in the red, and Wall Street's fear gauge, the Cboe Volatility index, closing at its highest level since Dec. 21.In the minutes from the Fed's Dec. 14-15 policy meeting, central bank policymakers said a \"very tight\" job market and unabated inflation might require the Fed to raise rates sooner and begin reducing its overall asset holdings as a second brake on the economy.\"Indications that the Fed is very concerned about inflation could quickly create a view that the Fed will aggressively tighten in 2022,\" said David Carter, chief investment officer at Lenox Wealth Advisors in New York, calling the minutes \"more hawkish than expected.\"The S&P 500 technology sector fell 3.1% and was the biggest drag on the benchmark index, while the rate-sensitive real estate sector dropped 3.2% in its biggest daily percentage decline since Jan. 4, 2021.The Dow Jones Industrial Average fell 392.54 points, or 1.07%, to 36,407.11, the S&P 500 lost 92.96 points, or 1.94%, to 4,700.58 and the Nasdaq Composite dropped 522.54 points, or 3.34%, to 15,100.17.Rising interest rates increase borrowing costs for businesses and consumers, and higher rates can depress stock multiples, especially for technology and other growth stocks.Growth shares have been under pressure from a recent rise in U.S. Treasury yields.The Russell 2000 index also suffered its biggest one-day drop since Nov. 26, while the S&P 500 financials index fell 1.3%, a day after it registered an all-time closing high.Policymakers in December agreed to hasten the end of their pandemic-era program of bond purchases, and issued forecasts anticipating three quarter-percentage-point rate increases during 2022. The Fed's benchmark overnight interest rate is currently set near zero.Early in the day, an ADP National Employment report showed private payrolls increased by 807,000 jobs last month, more than double of what economists polled by Reuters had forecast.The report comes ahead of the Labor Department's more comprehensive and closely watched nonfarm payrolls data for December on Friday.Declining issues outnumbered advancing ones on the NYSE by a 4.32-to-1 ratio; on Nasdaq, a 4.22-to-1 ratio favored decliners.The S&P 500 posted 59 new 52-week highs and 1 new lows; the Nasdaq Composite recorded 81 new highs and 307 new lows.Volume on U.S. exchanges was 12.18 billion shares, compared with the 10.4 billion average for the full session over the last 20 trading days.","news_type":1},"isVote":1,"tweetType":1,"viewCount":125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"hots":[{"id":9008871847,"gmtCreate":1641426609993,"gmtModify":1676533613310,"author":{"id":"4099390898791420","authorId":"4099390898791420","name":"LalaChin","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"BUY.","listText":"BUY.","text":"BUY.","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":5,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9008871847","repostId":"2201255535","repostType":2,"isVote":1,"tweetType":1,"viewCount":125,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9004660605,"gmtCreate":1642584671029,"gmtModify":1676533725062,"author":{"id":"4099390898791420","authorId":"4099390898791420","name":"LalaChin","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"All Zogenix shareholders are&nbsp;on drugs now🤪","listText":"All Zogenix shareholders are&nbsp;on drugs now🤪","text":"All Zogenix shareholders are on drugs now🤪","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9004660605","repostId":"1154721698","repostType":4,"repost":{"id":"1154721698","weMediaInfo":{"introduction":"Providing stock market headlines, business news, financials and earnings ","home_visible":1,"media_name":"Tiger Newspress","id":"1079075236","head_image":"https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba"},"pubTimestamp":1642583987,"share":"https://www.laohu8.com/m/news/1154721698?lang=&edition=full","pubTime":"2022-01-19 17:19","market":"us","language":"en","title":"Zogenix Shares Popped 56% in Premarket Trading","url":"https://stock-news.laohu8.com/highlight/detail?id=1154721698","media":"Tiger Newspress","summary":"Zogenix shares popped 56% in premarket trading as UCB agreed to buy Zogenix for up to $1.9 billion.B","content":"<html><head></head><body><p>Zogenix shares popped 56% in premarket trading as UCB agreed to buy Zogenix for up to $1.9 billion.</p><p><img src=\"https://static.tigerbbs.com/92b5f5e39f76c65983922a9028031295\" tg-width=\"840\" tg-height=\"622\" referrerpolicy=\"no-referrer\"/></p><p>Belgian pharmaceutical company UCB SA agreed to buy Zogenix Inc., a U.S. maker of drugs to treat seizures and rare diseases, for as much as $1.9 billion, expanding its portfolio to treat epilepsy.</p><p>Investors will get $26 in cash for every Zogenix share, plus a potential $2 per share payment if the U.S. company’s Fintepla drug gets regulatory approval for Lennox-Gastaut syndrome by the end of 2023, UCB said Wednesday. The initial payment is 66% higher than Tuesday’s closing price.</p><p>Lennox-Gastaut syndrome is an orphan disease that causes seizures. UCB has been expanding in therapies for rare ailments, like many big rivals including Sanofi, Takeda Pharmaceutical Co. and Roche Holding AG, as they can charge more for unique life-saving drugs than for routine treatments.</p><p>UCB shares fell as much as 0.9% in Brussels Wednesday morning.</p><p>Fintepla has already received regulatory approval in the U.S. and European Union for seizures caused by Dravet syndrome, a rare form of epilepsy.</p><p>UCB said it will finance the deal with cash and a loan. Lazard and Barclays are the company’s financial advisors, while Bank of America Securities and SVB Leerink advised Zogenix.</p></body></html>","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Zogenix Shares Popped 56% in Premarket Trading</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nZogenix Shares Popped 56% in Premarket Trading\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1079075236\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://static.tigerbbs.com/8274c5b9d4c2852bfb1c4d6ce16c68ba);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">Tiger Newspress </p>\n<p class=\"h-time\">2022-01-19 17:19</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><head></head><body><p>Zogenix shares popped 56% in premarket trading as UCB agreed to buy Zogenix for up to $1.9 billion.</p><p><img src=\"https://static.tigerbbs.com/92b5f5e39f76c65983922a9028031295\" tg-width=\"840\" tg-height=\"622\" referrerpolicy=\"no-referrer\"/></p><p>Belgian pharmaceutical company UCB SA agreed to buy Zogenix Inc., a U.S. maker of drugs to treat seizures and rare diseases, for as much as $1.9 billion, expanding its portfolio to treat epilepsy.</p><p>Investors will get $26 in cash for every Zogenix share, plus a potential $2 per share payment if the U.S. company’s Fintepla drug gets regulatory approval for Lennox-Gastaut syndrome by the end of 2023, UCB said Wednesday. The initial payment is 66% higher than Tuesday’s closing price.</p><p>Lennox-Gastaut syndrome is an orphan disease that causes seizures. UCB has been expanding in therapies for rare ailments, like many big rivals including Sanofi, Takeda Pharmaceutical Co. and Roche Holding AG, as they can charge more for unique life-saving drugs than for routine treatments.</p><p>UCB shares fell as much as 0.9% in Brussels Wednesday morning.</p><p>Fintepla has already received regulatory approval in the U.S. and European Union for seizures caused by Dravet syndrome, a rare form of epilepsy.</p><p>UCB said it will finance the deal with cash and a loan. Lazard and Barclays are the company’s financial advisors, while Bank of America Securities and SVB Leerink advised Zogenix.</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"ZGNX":"Zogenix"},"source_url":"","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"1154721698","content_text":"Zogenix shares popped 56% in premarket trading as UCB agreed to buy Zogenix for up to $1.9 billion.Belgian pharmaceutical company UCB SA agreed to buy Zogenix Inc., a U.S. maker of drugs to treat seizures and rare diseases, for as much as $1.9 billion, expanding its portfolio to treat epilepsy.Investors will get $26 in cash for every Zogenix share, plus a potential $2 per share payment if the U.S. company’s Fintepla drug gets regulatory approval for Lennox-Gastaut syndrome by the end of 2023, UCB said Wednesday. The initial payment is 66% higher than Tuesday’s closing price.Lennox-Gastaut syndrome is an orphan disease that causes seizures. UCB has been expanding in therapies for rare ailments, like many big rivals including Sanofi, Takeda Pharmaceutical Co. and Roche Holding AG, as they can charge more for unique life-saving drugs than for routine treatments.UCB shares fell as much as 0.9% in Brussels Wednesday morning.Fintepla has already received regulatory approval in the U.S. and European Union for seizures caused by Dravet syndrome, a rare form of epilepsy.UCB said it will finance the deal with cash and a loan. Lazard and Barclays are the company’s financial advisors, while Bank of America Securities and SVB Leerink advised Zogenix.","news_type":1},"isVote":1,"tweetType":1,"viewCount":132,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9965520814,"gmtCreate":1669988083739,"gmtModify":1676538283469,"author":{"id":"4099390898791420","authorId":"4099390898791420","name":"LalaChin","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"[Drowsy]&nbsp;","listText":"[Drowsy]&nbsp;","text":"[Drowsy]","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":4,"commentSize":1,"repostSize":0,"link":"https://ttm.financial/post/9965520814","repostId":"1188313465","repostType":4,"isVote":1,"tweetType":1,"viewCount":10,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0},{"id":9021477689,"gmtCreate":1653098739342,"gmtModify":1676535223816,"author":{"id":"4099390898791420","authorId":"4099390898791420","name":"LalaChin","avatar":"https://static.laohu8.com/default-avatar.jpg","crmLevel":8,"crmLevelSwitch":1,"followedFlag":false},"themes":[],"htmlText":"Buy buy buy&nbsp;","listText":"Buy buy buy&nbsp;","text":"Buy buy buy","images":[],"top":1,"highlighted":1,"essential":1,"paper":1,"likeSize":2,"commentSize":0,"repostSize":0,"link":"https://ttm.financial/post/9021477689","repostId":"2236015712","repostType":2,"repost":{"id":"2236015712","pubTimestamp":1653088476,"share":"https://www.laohu8.com/m/news/2236015712?lang=&edition=full","pubTime":"2022-05-21 07:14","market":"us","language":"en","title":"Buy Apple Stock for Resiliency During the Tech Sell-Off","url":"https://stock-news.laohu8.com/highlight/detail?id=2236015712","media":"Motley Fool","summary":"Here's why Apple is a golden investment amid the ongoing tech sell-off.","content":"<html><head></head><body><p>The stock market has been a circus show in recent history, due to record-high inflation levels, the Fed&#39;s decision to raise interest rates in response, and lingering concerns in connection to the war between Russia and Ukraine. Consequently, the <b>S&amp;P 500</b> and <b>Nasdaq Composite</b> have backtracked 15% and 24% year to date, respectively, with no end to the negativism in sight.</p><p>Even big tech has struggled, with premier companies <b>Netflix </b>and <b><a href=\"https://laohu8.com/S/FB\">Meta Platforms</a></b> posting weaker-than-anticipated financial reports in recent quarters. The panic has sent investors swarming to value stocks and safer assets for protection, leaving the technology sector drowning in the red. But as long-term investors, this doesn&#39;t mean that we should completely ignore tech stocks for the time being.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/58efc5f5899a865afd71defde8137f91\"/><span>Image source: Getty Images.</span></p><p>In fact, there are several companies that continue to deliver strong financial results in spite of the challenges our current economy presents. One of those companies,<b> Apple</b>, is a world-beater that can provide investors with much-needed security in today&#39;s market environment. And since it&#39;s down almost 20% year to date, the technology juggernaut grants investors a handsome valuation at present levels.</p><h2>A resilient business</h2><p>In the past 12 quarters, Apple has beaten earnings estimates each time, and the company has only fallen short of Wall Street&#39;s revenue forecasts once. In the second quarter of 2022, the tech leader increased both total sales and earnings per share by 9% year over year, up to $97.3 billion and $1.52, respectively. While its product category -- which includes the iPhone, iPad, and Mac -- only grew a modest 7%, the company&#39;s services segment surged 17% to $19.8 billion.</p><p>For the full fiscal year 2022, analysts are forecasting Apple&#39;s top line to improve 8% to $394.2 billion and its earnings per share to increase 10% to $6.15. Investors should like where the iPhone maker is positioned today. Not only does its world-class core business offer stability on top of its persistent growth, but the company&#39;s services segment enjoys a long runway for expansion in the years ahead.</p><p>Fortunately for Apple and its shareholders, the company&#39;s elite balance sheet and cash generation will comfortably facilitate growth for the tech giant in the future. The company has $28.1 billion in cash on its balance sheet, and it continues to generate funds at a red-hot pace. In the past 12 months, Apple has produced $105.8 billion in free cash flow (FCF), and its three-year FCF compound annual growth rate (CAGR) is 13%. The company&#39;s robust balance sheet and consistent cash generation provide financial flexibility to increase its dividends, buy back shares, and grow its business in the years to follow.</p><h2>A normalized valuation</h2><p>The recent stock price pullback year to date has made Apple stock a very tempting buy. The stock carries a price-to-earnings multiple of 24 today, representing its lowest trading level since the early summer of 2020.</p><p class=\"t-img-caption\"><img src=\"https://static.tigerbbs.com/2ff26f227883e6475edef412754fe00f\" tg-width=\"720\" tg-height=\"433\" width=\"100%\" height=\"auto\"/><span>AAPL PE Ratio data by YCharts</span></p><p>The tech company&#39;s current earnings multiple is also largely in line with its five-year historical average of 23. But given that Apple has been able to maintain solid growth in recent quarters -- especially compared to the rest of big tech -- investors should be thrilled about buying the stock at existing levels.</p><h2>Apple is a good play on the turbulent stock market today</h2><p>Apple is a wise investment today -- the world-leading technology company continues to expand its business at a steady rate in an economy where many of its peers are suffering from growing pains. The stock is also trading at its lowest valuation since mid-2020, supplying investors with a favorable margin of safety. If you&#39;re searching for a durable stock to combat the market&#39;s volatility today, Apple might be the choice for you.</p></body></html>","source":"fool_stock","collect":0,"html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Buy Apple Stock for Resiliency During the Tech Sell-Off</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nBuy Apple Stock for Resiliency During the Tech Sell-Off\n</h2>\n\n<h4 class=\"meta\">\n\n\n2022-05-21 07:14 GMT+8&nbsp;&nbsp;&nbsp;<a href=https://www.fool.com/investing/2022/05/20/buy-apple-stock-resiliency-during-tech-sell-off/><strong>Motley Fool</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>The stock market has been a circus show in recent history, due to record-high inflation levels, the Fed's decision to raise interest rates in response, and lingering concerns in connection to the war ...</p>\n\n<a href=\"https://www.fool.com/investing/2022/05/20/buy-apple-stock-resiliency-during-tech-sell-off/\">Web Link</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","type":0,"thumbnail":"","relate_stocks":{"AAPL":"苹果"},"source_url":"https://www.fool.com/investing/2022/05/20/buy-apple-stock-resiliency-during-tech-sell-off/","is_english":true,"share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","article_id":"2236015712","content_text":"The stock market has been a circus show in recent history, due to record-high inflation levels, the Fed's decision to raise interest rates in response, and lingering concerns in connection to the war between Russia and Ukraine. Consequently, the S&P 500 and Nasdaq Composite have backtracked 15% and 24% year to date, respectively, with no end to the negativism in sight.Even big tech has struggled, with premier companies Netflix and Meta Platforms posting weaker-than-anticipated financial reports in recent quarters. The panic has sent investors swarming to value stocks and safer assets for protection, leaving the technology sector drowning in the red. But as long-term investors, this doesn't mean that we should completely ignore tech stocks for the time being.Image source: Getty Images.In fact, there are several companies that continue to deliver strong financial results in spite of the challenges our current economy presents. One of those companies, Apple, is a world-beater that can provide investors with much-needed security in today's market environment. And since it's down almost 20% year to date, the technology juggernaut grants investors a handsome valuation at present levels.A resilient businessIn the past 12 quarters, Apple has beaten earnings estimates each time, and the company has only fallen short of Wall Street's revenue forecasts once. In the second quarter of 2022, the tech leader increased both total sales and earnings per share by 9% year over year, up to $97.3 billion and $1.52, respectively. While its product category -- which includes the iPhone, iPad, and Mac -- only grew a modest 7%, the company's services segment surged 17% to $19.8 billion.For the full fiscal year 2022, analysts are forecasting Apple's top line to improve 8% to $394.2 billion and its earnings per share to increase 10% to $6.15. Investors should like where the iPhone maker is positioned today. Not only does its world-class core business offer stability on top of its persistent growth, but the company's services segment enjoys a long runway for expansion in the years ahead.Fortunately for Apple and its shareholders, the company's elite balance sheet and cash generation will comfortably facilitate growth for the tech giant in the future. The company has $28.1 billion in cash on its balance sheet, and it continues to generate funds at a red-hot pace. In the past 12 months, Apple has produced $105.8 billion in free cash flow (FCF), and its three-year FCF compound annual growth rate (CAGR) is 13%. The company's robust balance sheet and consistent cash generation provide financial flexibility to increase its dividends, buy back shares, and grow its business in the years to follow.A normalized valuationThe recent stock price pullback year to date has made Apple stock a very tempting buy. The stock carries a price-to-earnings multiple of 24 today, representing its lowest trading level since the early summer of 2020.AAPL PE Ratio data by YChartsThe tech company's current earnings multiple is also largely in line with its five-year historical average of 23. But given that Apple has been able to maintain solid growth in recent quarters -- especially compared to the rest of big tech -- investors should be thrilled about buying the stock at existing levels.Apple is a good play on the turbulent stock market todayApple is a wise investment today -- the world-leading technology company continues to expand its business at a steady rate in an economy where many of its peers are suffering from growing pains. The stock is also trading at its lowest valuation since mid-2020, supplying investors with a favorable margin of safety. If you're searching for a durable stock to combat the market's volatility today, Apple might be the choice for you.","news_type":1},"isVote":1,"tweetType":1,"viewCount":91,"authorTweetTopStatus":1,"verified":2,"comments":[],"imageCount":0,"langContent":"EN","totalScore":0}],"lives":[]}